Search

everythinglearnresearchcommunity

for

Search:↓

Disease-specific tools better assess alopecia areata's impact on quality of life.

Taohong Siwu Decoction may help treat hair loss by targeting multiple genes and pathways.

Both Unani treatments effectively reduced hair shedding in Telogen Effluvium.

Finasteride can cause depression and suicidal thoughts; safer alternatives are recommended.

Children's books on alopecia and trichotillomania often miss important treatment information.

Alopecia areata significantly impacts patients' mental health and quality of life.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

The document concludes that more research is needed to confirm if blood tests for things like iron and vitamin D are helpful for hair loss from Telogen effluvium.

Detailed history and physical examination are crucial for diagnosing hair loss.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Psychological therapies may improve quality of life for people with alopecia areata.

The document concludes that hirsutism in women, often caused by PCOS, requires systematic evaluation and can be treated with medications, mechanical removal, or cosmetic methods, with weight loss also being beneficial.

Caregivers of chronic skin disease patients face significant burdens that harm their quality of life.

Psychological and social responses to scars can indicate mental health risks.

SLE patients often face depression and anxiety due to physical changes, with African-American and Hispanic patients having higher unmet psychological needs.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.

Alopecia areata affects 1.45% of people in Japan, impacting mood and self-esteem, with many not seeking treatment.

Reducing accidents and treating vascular diseases can lower the need for life-impacting amputations.

Alopecia areata greatly affects the quality of life for children and their families.

Alopecia areata patients have worse quality of life, anxiety, and depression than vitiligo patients.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

The Swedish Hairdex-S is a reliable tool for assessing quality of life in Alopecia Areata patients.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

A new method accurately measures college students' mental health by considering time perception and clustering techniques.

Negative views about alopecia worsen quality of life and increase anxiety and depression.

Behavioral interventions, especially habit reversal training, are most effective for treating trichotillomania in children.